Abiopharma

Mushrooms Inc., (MSVI), a publicly held company, is actively supporting the growth of the mushroom market through acquisitions of and collaborations with pioneers and innovators in the mushroom industry. This rapidly growing market has many untapped avenues for the creation of environmentally beneficial products and health products. The company filed a full-utility-patent in October of 2023 which relates to methods of producing products for bacterial detection, bacterial growth inhibition, nutrient delivery and, more particularly, to a method of generating multifunctional mycelium products, such as thread, foam, films, gels, and liquids. Mushrooms Inc. is at the forefront of a healthcare revolution, with a vision to transform how bacterial infections are detected and managed through a patent pending mycelium based textile. This groundbreaking Bacterial Detection Bandage, that we call Medical Mycellius, identifies bacterial invasion at the wound site through a color change. This exemplifies our commitment to innovation, patient safety, and sustainable healthcare solutions. Mushrooms Inc. is immersed in a vibrant business, and creation-oriented environment where the company has access relationships with top SEC attorneys, accounting firms, investment bankers, and qualified management teams.

Additional info from OTC:
Mushrooms Inc., (MSVI), a publicly held company, is actively supporting the growth of the mushroom market through acquisitions of and collaborations with pioneers and innovators in the mushroom industry. This rapidly growing market has many untapped avenues for the creation of environmentally beneficial products and health products. The company filed a full-utility-patent in October of 2023 which relates to methods of producing products for bacterial detection, bacterial growth inhibition, nutrient delivery and, more particularly, to a method of generating multifunctional mycelium products, such as thread, foam, films, gels, and liquids. Mushrooms Inc. is at the forefront of a healthcare revolution, with a vision to transform how bacterial infections are detected and managed through a patent pending mycelium based textile. This groundbreaking Bacterial Detection Bandage, that we call Medical Mycellius, identifies bacterial invasion at the wound site through a color change. This exemplifies our commitment to innovation, patient safety, and sustainable healthcare solutions. Mushrooms Inc. is immersed in a vibrant business, and creation-oriented environment where the company has access relationships with top SEC attorneys, accounting firms, investment bankers, and qualified management teams.